Carcinoma of endocrine organs: Results of the RARECARE project

European Journal of Cancer

Volumn 48, Issue 13, 2012, Pages 1923-1931

  Van Der Zwan, Jan Maarten ^a   Mallone, Sandra ^b   Van Dijk, Boukje ^a   Bielska Lasota, Magdalena ^c   Otter, Renée ^a   Foschi, Roberto ^d   Baudin, Eric ^e   Links, Thera P ^f   Zielonk, N ^g   Van Eycken, E ^h   Sundseth, H ⁱ   Hedelin, G ^j   Faivre, J ^k   Woronoff, A S ^l   Buemi, A ^m   Tretarre, B ⁿ   Colonna, M ^o   Bara, S ^p   Ganry, O ^q   Grosclaude, P ^r   Holleczek, B ^s   Geissler, J ^t   Tryggvadottir, L ^u   Deady, S ^v   Bellu F ^w   Ferretti, S ^x   Serraino, D ^y   Vercelli, M ^z   Vitarelli, S ^aa   Cirilli, C ^ab   Fusco, M ^ac   Traina, A ^ad   Bozzani, F ^ae   Giacomin, A ^af   Tumino, R ^ag   Mangone, L ^ah   Falcini, F ^ai   Senatore, G ^aj   Budroni, M ^ak   Piffer, S ^al   Crocetti, E ^am   La Rosa, F ^an   Tagliabue, G ^ao   Fiore, A ^ap   Casali, P G ^d   Gronchi, A ^d   Ruzza, M ^d   Sowe, S ^d   Trama, A ^d   De Angelis, R ^b   Tavilla, A ^b   Dei Tos, A P ^aq   England, K ^ar   Ursin, G ^as   Rachtan, J ^at   Gozdz, S ^au   Zwierko, M ^av   Slowinski, J ^aw   Miranda, A ^ax   Safaei Diba, Ch ^ay   Primic Zakelj, M ^az   Mateos, A ^ba   Martinez R ^bb   Torrella Ramos, A ^bc   Marcos Gragera, R ^bd   Chirlaque, M D ^be,bf   Moreno, C ^bg   Galceran, J ^bh   Martinez Garcia, C ^bi   Melchor, J M ^bi   Sanchez M J ^bi   Virizuela Echaburu, J A ^bj   Cervantes, A ^bk   Adolfsson, J ^bl   Lambe, M ^bm   Moller T R ^bn   Ringborg, U ^bo   Jundt, G ^bp   Bouchardy, C ^bq   Ess, S M ^br   Bordoni, A ^bs   Konzelmann, I ^bt   Lutz, J M ^bu   Visser, O ^a   Otter, R ^a   Siesling, S ^a   Coebergh, J W W ^bv   Greenberg, D C ^bw   Wilkinson, J ^bx   Roche, M ^by   Verne, J ^bz   Meechan, D ^ca   Lawrence, G ^cb   Coleman, M P ^cc   Mackay, J ^cd   Gavin, A ^ce   Brewster, D H ^cf   Kunkler, I ^cg   White, C ^ch   more..

^a Department of Cancer Registry and Research   (Netherlands)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE OF HYGIENE   (Poland)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g Austrian National Cancer Registry   (Austria)

^h Belgian Cancer Registry   (Belgium)

ⁱ European Cancer Patient Coalition   (Belgium)

^j Cancer Registry of Bas Rhin   (France)

^k Côte D'Or Digestive Cancer Registry   (France)

^l Doubs Cancer Registry   (France)

^m Haut Rhin Cancer Registry   (France)

ⁿ Herault Cancer Registry   (France)

^o Isere's Cancer Registry   (France)

^p Manche Cancer Registry   (France)

^q Somme Cancer Registry   (France)

^r Tarn Cancer Registry   (France)

^s Saarland Cancer Registry   (Germany)

^t CML Advocates Network   (Germany)

^u ICELANDIC CANCER REGISTRY   (Iceland)

^v National Cancer Registry of Ireland   (Ireland)

^w Alto Adige Cancer Registry   (Italy)

^x Ferrara Cancer Registry   (Italy)

^y Friuli Venezia Giulia Cancer Registry   (Italy)

^z UNIVERSITY OF GENOA   (Italy)

^aa Macerata Province Cancer Registry   (Italy)

^ab MODENA CANCER REGISTRY   (Italy)

^ac Napoli Cancer Registry   (Italy)

^ad Palermo Breast Cancer Registry   (Italy)

^ae PARMA CANCER REGISTRY   (Italy)

^af Piedmont Cancer Registry   (Italy)

^ag CIVILE M P AREZZO HOSPITAL   (Italy)

^ah Reggio Emilia Cancer Registry   (Italy)

^ai Romagna Cancer Registry   (Italy)

^aj Salerno Cancer Registry   (Italy)

^ak Sassari Cancer Registry   (Italy)

^al Osservatorio Epidemiologico   (Italy)

^am Tuscan Cancer Registry   (Italy)

^an Umbria Cancer Registry   (Italy)

^ao Varese Cancer Registry   (Italy)

^ap Veneto Cancer Registry   (Italy)

^aq Local Health Unit No 9 Region of Veneto   (Italy)

^ar Malta National Cancer Registry   (Malta)

^as CANCER REGISTRY OF NORWAY   (Norway)

^at Cracow Cancer Registry   (Poland)

^au Cancer Registry of Kielce   (Poland)

^av INSTITUTE OF ONCOLOGY   (Poland)

^aw MEDICAL UNIVERSITY OF SILESIA   (Poland)

^ax Southern Portugal Cancer Registry   (Portugal)

^ay National Cancer Registry of   (Slovakia)

^az INSTITUTE OF ONCOLOGY   (Slovenia)

^ba Albacete Cancer Registry   (Spain)

^bb Departamento de Sanidad Gobierno Vasco   (Spain)

^bc Castillon Cancer Registry   (Spain)

^bd CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^be Murcia Regional Health Authority   (Spain)

^bf CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^bg Navarra Cancer Registry   (Spain)

^bh Tarragona Cancer Registry   (Spain)

^bi ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^bj HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^bk UNIVERSITY OF VALENCIA   (Spain)

^bl Regional Cancer Center Stockholm and Gotland   (Sweden)

^bm Regional Cancer Center Uppsala Orebro   (Sweden)

^bn LUND UNIVERSITY HOSPITAL   (Sweden)

^bo KAROLINSKA INSTITUTE   (Sweden)

^bp Cancer Registry of Basel   (Switzerland)

^bq GENEVA CANCER REGISTRY   (Switzerland)

^br St Gallen Cancer Registry   (Switzerland)

^bs Ticino Cancer Registry   (Switzerland)

^bt Valais Cancer Registry   (Switzerland)

^bu National Institute for Cancer Epidemiology and Registration   (Switzerland)

^bv Eindhoven Cancer Registry   (Netherlands)

^bw Eastern Cancer Registration and Information Centre   (United Kingdom)

^bx Northern and Yorkshire Cancer Registry   (United Kingdom)

^by UNIVERSITY OF OXFORD   (United Kingdom)

^bz South West Cancer Intelligence Service   (United Kingdom)

^ca Trent Cancer Registry   (United Kingdom)

^cb W Midlands Cancer Intelligence Unit   (United Kingdom)

^cc LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^cd UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ce Northern Ireland Cancer Registry   (United Kingdom)

^cf Scottish Cancer Registry   (United Kingdom)

^cg UNIVERSITY OF EDINBURGH   (United Kingdom)

^ch Welsh Cancer Intelligence Surveillance Unit   (United Kingdom)

more..

Author keywords

Endocrine carcinoma; Europe; Incidence; Population based study; Prevalence; Rare cancer; Survival

Indexed keywords

ADRENAL CORTEX CARCINOMA; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; ENDOCRINE TUMOR; EUROPE; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; PARATHYROID CARCINOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL TIME; THYROID CANCER;

EID: 84865123659     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.01.029     Document Type: Article

References (32)

1. J.P. Monson The epidemiology of endocrine tumours Endocr Relat Cancer 7 1 2000 29 36 (Pubitemid 30305869)
2. A. Fritz, C. Percy, and A. Jack International Classification of Disease for Oncology 3rd ed. 2000 World Health Organization Geneva
3. Gatta, van der Zwan, Siesling, et al. Technical Report with Basic Indicators for Rare Cancers and Health Care Related Macro Indicators. rarecare 2010 June 9. Available from: URL: http://www.rarecare.eu/rare-indicators/WP5- Technical-Report.pdf.
4. R. Capocaccia, M. Colonna, and I. Corazziari Measuring cancer prevalence in Europe: the EUROPREVAL project Ann Oncol 13 6 2002 831 839 (Pubitemid 34752679)
5. R. Capocaccia, and A.R. De Estimating the completeness of prevalence based on cancer registry data Stat Med 16 4 1997 425 440 (Pubitemid 27073011)
6. A.R. De, R. Capocaccia, T. Hakulinen, B. Soderman, and A. Verdecchia Mixture models for cancer survival analysis: application to population-based data with covariates Stat Med 18 4 1999 441 454 (Pubitemid 29057371)
7. H. Brenner, V. Arndt, O. Gefeller, and T. Hakulinen An alternative approach to age adjustment of cancer survival rates Eur J Cancer 40 15 2004 2317 2322 (Pubitemid 39348883)
8. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, vol. IX. IARC Sci Publ; 2007, (160), 68, 280, 314, 317.
9. P. Correa, and V.W. Chen Endocrine gland cancer Cancer 75 1 1995 338 352
10. P.K. Lee, S.L. Jarosek, B.A. Virnig, M. Evasovich, and T.M. Tuttle Trends in the incidence and treatment of parathyroid cancer in the United States Cancer 109 9 2007 1736 1741 (Pubitemid 46668534)
11. M.F. Chiang, M. Brock, and S. Patt Pituitary metastases Neurochirurgia (Stuttg) 33 4 1990 127 131 (Pubitemid 20221753)
12. B.W. Scheithauer, O. Kurtkaya-Yapicier, K.T. Kovacs, W.F. Young Jr., and R.V. Lloyd Pituitary carcinoma: a clinicopathological review Neurosurgery 56 5 2005 1066 1074 (Pubitemid 40628116)
13. B.T. Ragel, and W.T. Couldwell Pituitary carcinoma: a review of the literature Neurosurg Focus 16 4 2004 E7
14. P.J. Pernicone, B.W. Scheithauer, and T.J. Sebo Pituitary carcinoma: a clinicopathologic study of 15 cases Cancer 79 4 1997 804 812 (Pubitemid 27076347)
15. I. dos Santos Silva, and A.J. Swerdlow Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution Br J Cancer 67 2 1993 330 340 (Pubitemid 23049558)
16. J.A. Sipos, and E.L. Mazzaferri Thyroid cancer epidemiology and prognostic variables Clin Oncol 22 6 2010 395 404
17. A.J. Taylor, A.P. Croft, and A.M. Palace Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study Int J Cancer 125 10 2009 2400 2405
18. E. Steliarova-Foucher, C.A. Stiller, and E. Pukkala Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project Eur J Cancer 42 13 2006 2150 2169 (Pubitemid 44224059)
19. P. Boyle, and B. Levin World cancer report 2008 IARC Press Lyon
20. The Chernobyl Forum Expert Group 'Environment'. Environmental consequences of the chernobyl accident and their remediation: twenty years of experience. Vienna: International Atomic Energy Agency; 2006.
21. E. Negri, E. Ron, and S. Franceschi Risk factors for medullary thyroid carcinoma: a pooled analysis Cancer Causes Control 13 4 2002 365 372 (Pubitemid 34553517)
22. L. Teppo, and T. Hakulinen Variation in survival of adult patients with thyroid cancer in Europe Eur J Cancer 34 14 1998 2248 2252 (Pubitemid 29036894)
23. F.A. Candanedo-Gonzalez, and A. Gamboa-Dominguez Postmenopause is associated with recurrence of differentiated papillary thyroid carcinoma Med Hypotheses 69 1 2007 209 213 (Pubitemid 46711075)
24. Ries LA, KrapchoM, Mariotto A. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute 2011 June 20. Available from: URL: http://seer.cancer.gov/csr/1975/2007/results/merged/sect/26/thyroid.pdf.
25. F.D. Gilliland, W.C. Hunt, D.M. Morris, and C.R. Key Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991 Cancer 79 3 1997 564 573 (Pubitemid 27051783)
26. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 86 3 1999 538 544 (Pubitemid 29347419)
27. T. Obara, and Y. Fujimoto Diagnosis and treatment of patients with parathyroid carcinoma: an update and review World J Surg 15 6 1991 738 744
28. A.R. Shaha, and J.P. Shah Parathyroid carcinoma: a diagnostic and therapeutic challenge Cancer 86 3 1999 378 380 (Pubitemid 29347397)
29. M. Schaapveld, F.H. Jorna, and K.K. Aben Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis Am J Surg 202 5 2011 590 597
30. B.L. Paton, Y.W. Novitsky, and M. Zerey Outcomes of adrenal cortical carcinoma in the United States Surgery 140 6 2006 914 920 (Pubitemid 44937380)
31. M.D. Wooten, and D.K. King Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature Cancer 72 11 1993 3145 3155 (Pubitemid 23356754)
32. D. Kopf, P.E. Goretzki, and H. Lehnert Clinical management of malignant adrenal tumors J Cancer Res Clin Oncol 127 3 2001 143 155 (Pubitemid 32449065)